产品标题 |
产品货号 |
产品规格 |
厂家 |
Human DNA: Breast; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIES | CD563256 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Breast; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIES | CD563573 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Breast; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIES | CD563283 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Breast; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIES | CD563738 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Breast; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIES | CD564103 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Breast; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIES | CD564348 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Breast; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIES | CD564349 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Breast; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIES | CD564555 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Breast; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIES | CD564671 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Breast; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIES | CD564716 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Breast; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIES | CD564916 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Breast; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIES | CD565005 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Breast; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIES | CD564648 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Breast; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIES | CD565139 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Breast-Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIES | CD565917 | n/a | ORIGENE TECHNOLOGIES |
Human DNA: Breast; Adenocarcinoma of breast, metaplastic, recurrent from ORIGENE TECHNOLOGIES | CD565209 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Breast; Adenocarcinoma of breast, metastatic from ORIGENE TECHNOLOGIES | CD564327 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Breast; Adenocarcinoma of breast, metastatic from ORIGENE TECHNOLOGIES | CD564813 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Breast; Adenosis of breast, sclerosing from ORIGENE TECHNOLOGIES | CD564080 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Breast; Adenosis of breast, sclerosing from ORIGENE TECHNOLOGIES | CD565006 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Breast; Carcinoma in situ of breast, ductal, cribriform, solid from ORIGENE TECHNOLOGIES | CD563421 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Breast; Adenocarcinoma of breast, micropapillary from ORIGENE TECHNOLOGIES | CD563588 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Breast; Ductal hyperplasia of breast from ORIGENE TECHNOLOGIES | CD564717 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Breast; Fibrocystic breast disease from ORIGENE TECHNOLOGIES | CD563194 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Breast; Fibrocystic breast disease from ORIGENE TECHNOLOGIES | CD564468 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Breast; Fibrocystic breast disease from ORIGENE TECHNOLOGIES | CD563997 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Breast; Fibrocystic breast disease from ORIGENE TECHNOLOGIES | CD564574 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Breast; Fibrocystic changes of breast, atypical from ORIGENE TECHNOLOGIES | CD563607 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Breast; Fibrocystic breast disease from ORIGENE TECHNOLOGIES | CD564729 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Breast; Fibrocystic breast disease from ORIGENE TECHNOLOGIES | CD564799 | 5 ug | ORIGENE TECHNOLOGIES |
Human STEAP family member 4 (STEAP4) from ORIGENE TECHNOLOGIES | TP316917 | 20 ug | ORIGENE TECHNOLOGIES |
Human STEAP family member 3 (STEAP3), transcript variant 2 from ORIGENE TECHNOLOGIES | TP324274 | 20 ug | ORIGENE TECHNOLOGIES |
Human STEAP family member 3 (STEAP3), transcript variant 3 from ORIGENE TECHNOLOGIES | TP310595 | 20 ug | ORIGENE TECHNOLOGIES |
BCMA/TNFRSF17 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN208851 | 1 kit | ORIGENE TECHNOLOGIES |
BCMA/TNFRSF17 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN208851BN | 1 kit | ORIGENE TECHNOLOGIES |
BCMA/TNFRSF17 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN208851LP | 1 kit | ORIGENE TECHNOLOGIES |
BCMA/TNFRSF17 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN208851RB | 1 kit | ORIGENE TECHNOLOGIES |
BCMA/TNFRSF17 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN408851 | 1 kit | ORIGENE TECHNOLOGIES |
BCMA/TNFRSF17 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN517980 | 1 kit | ORIGENE TECHNOLOGIES |
BCMO1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN423790 | 1 kit | ORIGENE TECHNOLOGIES |
Bcmo1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN502118 | 1 kit | ORIGENE TECHNOLOGIES |
BCMO1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH323790 | 10 ug | ORIGENE TECHNOLOGIES |
BCO2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN418635 | 1 kit | ORIGENE TECHNOLOGIES |
Complement component 2 (C2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY400024 | 100 ug | ORIGENE TECHNOLOGIES |
Complement component 2 (C2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY429041 | 100 ug | ORIGENE TECHNOLOGIES |
Complement component 6 (C6), transcript variant 1 from ORIGENE TECHNOLOGIES | LY400016 | 100 ug | ORIGENE TECHNOLOGIES |
Complement component 6 (C6), transcript variant 2 from ORIGENE TECHNOLOGIES | LY426524 | 100 ug | ORIGENE TECHNOLOGIES |
Complement component (3d/Epstein Barr virus) receptor 2 (CR2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY419676 | 100 ug | ORIGENE TECHNOLOGIES |
Complement component 8, gamma polypeptide (C8G) from ORIGENE TECHNOLOGIES | LY424611 | 100 ug | ORIGENE TECHNOLOGIES |
Human macrophage scavenger receptor 1 (MSR1), transcript variant SR-AII from ORIGENE TECHNOLOGIES | TP312931 | 20 ug | ORIGENE TECHNOLOGIES |